The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.80
Bid: 64.20
Ask: 66.20
Change: 0.00 (0.00%)
Spread: 2.00 (3.115%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 65.80
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update

27 Nov 2018 07:00

RNS Number : 5496I
IDOX PLC
27 November 2018
 

27 November 2018

Idox plc

('Idox' or the 'Group' or the 'Company')

Year End Trading Update

 

ldox plc (AIM: IDOX), a leading supplier of specialist information management solutions and services, today issues a trading update for the twelve months ended 31 October 2018. 

The Group continues the transition to fully consolidate prior year acquisitions and refocus operations on our core profitable and cash generative activities to maximise shareholder value. As announced on 2 November 2018, the Group took the strategic decision to dispose of its loss-making Digital business.

The Group expects to report:

· consolidated revenues for the continuing business (excluding our Digital business disposed of on 2 November 2018) of £67.2m (2017: £73.5m restated). Consolidated revenues for the full year of all Group operations including our disposed Digital Business are expected to be £73.6m (2017: £86.3m restated).

· adjusted EBITDA† for the continuing business (excluding our Digital business disposed of on 2 November 2018) of £14.4m (2017: £16.7m restated). Adjusted EBITDA for the full year of all Group operations including our disposed Digital Business is expected to be £11.5m (2017: £16.1m restated).

· net debt position at 31 October 2018 of £31.7m (2017: £32.8m) comprising cash of £5.5m, third party borrowings of £25.7m and long term 2025 bond of £11.5m (2017: cash of £3.3m, third party borrowings of £24.7m and long term, 2025 bond of £11.4m)

The Group has appointed a new leadership team to drive value in the business with the appointment of Chris Stone as Non-Executive Chairman, Dave Meaden as Chief Executive Officer and Rob Grubb as Chief Financial Officer.

The Group has made progress with its core business in adjusting revenue profiles to align with the performance obligations of the services and solutions we deliver to our customers. The Group has also been focused on reducing the cost base to more appropriately match our business model to drive increased profitability and tightly manage working capital to ensure improved cash conversion.

The following provides an update on all these objectives, and excludes the Digital business to illustrate trends in the remaining core businesses of the Group going in to FY2019:

· Exit annualised recurring revenue run rate as at 31 October 2018 was £32.4m (as at 31 October 2017: £33.4m restated). Sustaining and improving levels of recurring revenues remains a priority.

· Our contracted order book for software and services has nearly doubled to £9.4m at 31 October 2018 (2017: approximately £4.0m), an increase of £5.4m reflecting revenue recognition commensurate with our performance obligations.

· Trade debtors and accrued income was £30.8m at 31 October 2018 (2017: £39.0m restated). The Group has a clear objective to reduce this further going into FY2019 and achieve higher cash conversion from its previous and ongoing activities.

· Our preparation for IFRS 15 has led to detailed review of how we recognise revenue in line with our performance obligations. As a result, it is anticipated that recurring revenues will form a higher proportion of the Group's revenues going forward compared to previous years.

· The majority of cost cutting during the year occurred in the now disposed Digital division. As part of the focus on increased profitability, costs in the continuing business (including employment costs, travel, marketing and other overheads) have reduced by £1.7m for the year ended 31 October 2018 to £44.0m (2017: £45.7m). This trend is expected to continue in to FY2019 and beyond as the Group adjusts its cost base to align more directly with its re-focused business model and drive increased profitability.

The Group expects to issue its FY2018 preliminary results announcement in February 2019.

Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition, corporate finance and share option costs.

 

David Meaden, Chief Executive of Idox, commented:

"FY2018 has seen a number of changes in the Idox business, but we end the financial year in a stronger position than we entered it and I am confident in our new leadership and team to deliver success in FY2019.

We continue to work hard to fully integrate prior year acquisitions and refocusing operations on our intellectual property and profitable cash generative activities. 

I am excited by the prospects for the business in FY2019 and future periods as we begin to reap the benefits of these ongoing efforts."

 

-Ends-

This announcement is released by Idox plc and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), encompassing information relating to the trading update described herein, and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Enquiries:

Idox plc

+44 (0) 870 333 7101

David Meaden, Chief Executive

Rob Grubb, Chief Financial Officer

N+1 Singer (NOMAD and Broker)

+44 (0) 20 7496 3000

Shaun Dobson / Jen Boorer (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

 

About Idox plc

For more information see www.idoxplc.com @Idoxgroup 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUNARRWKAAUUA
Date   Source Headline
7th Oct 20222:42 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSAcquisition
26th Sep 20227:00 amRNSExercise of Share Options & Total Voting Rights
1st Aug 20227:00 amRNSTotal Voting Rights
15th Jul 20227:00 amRNSIdox awarded new contract for Idox Cloud
28th Jun 20227:00 amRNSIssue of Equity
15th Jun 20227:00 amRNSHalf-year Report
19th May 20227:00 amRNSFY22 H1 trading update
19th Apr 202212:36 pmRNSHolding(s) in Company
5th Apr 20227:00 amRNSDirector/PDMR Shareholding
1st Apr 20227:00 amRNSGrant of Options
28th Mar 20227:13 amRNSExercise of Share Options & Total Voting Rights
23rd Mar 20229:51 amRNSExercise of Share Options & Total Voting Rights
16th Mar 202211:22 amRNSResult of AGM & Board Change
16th Mar 20227:00 amRNSAGM Trading Update
21st Feb 20227:01 amRNSPosting of Annual Report and Notice of AGM
21st Feb 20227:00 amRNSDirectorate Change
11th Feb 20228:46 amRNSGrant of Options
27th Jan 20227:40 amRNSProgressive publishes new research
27th Jan 20227:00 amRNSFinal Results
12th Jan 20227:00 amRNSNotice of Final Results
9th Dec 20219:50 amRNSIdox hosts company event focused on sustainability
25th Nov 20217:00 amRNSExercise of Share Options & Total Voting Rights
16th Nov 20217:00 amRNSYear End Trading Update
7th Oct 20218:08 amRNSHolding(s) in Company
5th Oct 20217:00 amRNSAcquisition
1st Oct 202111:25 amRNSExercise of Share Options & Total Voting Rights
9th Aug 20217:00 amRNSAcquisition
23rd Jul 20212:01 pmRNSHolding(s) in Company
19th Jul 20211:47 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSExercise of Share Options & Total Voting Rights
15th Jun 20217:00 amRNSHalf-year Report
7th Jun 20217:00 amRNSAcquisition
2nd Jun 20217:00 amRNSExercise of Share Options & Total Voting Rights
24th May 202111:40 amRNSInvestor presentation
20th May 20217:00 amRNSFY21 H1 Trading Update
23rd Apr 20214:00 pmRNSExercise of Share Options & Total Voting Rights
15th Apr 20211:41 pmRNSGrant of Options
13th Apr 20217:00 amRNSExercise of Share Options & Total Voting Rights
12th Apr 20219:40 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSFY21 Q1 Trading Update
22nd Mar 20212:46 pmRNSForm 8.3 - IDOX PLC
19th Mar 20219:07 amRNSForm 8.5 (EPT/RI) IDOX Plc
19th Mar 20217:01 amRNSDisposal of Idox Grants Consultancy business
19th Mar 20217:00 amRNSStatement regarding Dye & Durham’s withdrawal
18th Mar 20211:11 pmRNSResult of AGM
18th Mar 20218:34 amRNSForm 8.5 (EPT/RI) IDOX Plc
17th Mar 202110:51 amGNWForm 8.3 - IDOX PLC
17th Mar 20217:34 amRNSForm 8.5 (EPT/RI) IDOX Plc
16th Mar 20211:08 pmRNSForm 8.3 Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.